|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
See Header: Oth abnormal findings on diagnostic imaging of cnsl
ICD-10 (CM) Code and Descriptor
|
R90.89 |
Other abnormal findings on diagnostic imaging of central nervous system
|
R9089 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 23.04%
|
29.27%
|
18.81%
|
10.67%
|
6.04%
|
3.72%
|
2.31%
|
1.51%
|
1.19%
|
0.86%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R90.89*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
70553
|
MRI BRAIN STEM W/O & W/DYE |
2,567
|
2,573
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
1,540
|
1,550
|
|
70551
|
MRI BRAIN STEM W/O DYE |
1,179
|
1,180
|
|
A9585
|
GADOBUTROL INJECTION |
1,109
|
82,477
|
|
G1004
|
CDSM NDSC |
1,102
|
1,214
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
1,036
|
1,042
|
|
82565
|
ASSAY OF CREATININE |
693
|
693
|
|
70450
|
CT HEAD/BRAIN W/O DYE |
613
|
614
|
|
A9575
|
INJ GADOTERATE MEGLUMI 0.1ML |
598
|
78,877
|
|
A9577
|
INJ MULTIHANCE |
555
|
8,128
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
537
|
537
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
502
|
44,152
|
|
80053
|
COMPREHEN METABOLIC PANEL |
435
|
435
|
|
A9579
|
GAD-BASE MR CONTRAST NOS,1ML |
292
|
3,833
|
|
70496
|
CT ANGIOGRAPHY HEAD |
286
|
286
|
|
84443
|
ASSAY THYROID STIM HORMONE |
283
|
283
|
|
70544
|
MR ANGIOGRAPHY HEAD W/O DYE |
256
|
259
|
|
84157
|
ASSAY OF PROTEIN OTHER |
222
|
227
|
|
82945
|
GLUCOSE OTHER FLUID |
216
|
222
|
|
82607
|
VITAMIN B-12 |
207
|
207
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R90.89 related to the following DRG Codes:
947-948
|
